Application and Services

Twenty-five national medical guidelines or consensus of critical illness, liver disease, etc., recommend Jafron hemoadsorption therapy. And the therapy was also included in 11 national health care guidelines and recommendations for the treatment of Covid-19, including China, Morocco, the UK, Russia, Thailand, Iran, the Philippines, Columbia, Italy, India, Vietnam. With products, technologies and therapies available in 8,000 hospitals across more than 80 countries, the annual clinical application of Jafron reached 5 million cases.